Newspaper Publication for Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has filed a newspaper publication intimation with BSE regarding its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The results were published on August 13, 2025 in Business Standard (English, all editions) and Parshuram Samachar (Marathi, Mumbai edition), as required under SEBI LODR Regulation 47. This is a standard compliance disclosure and does not contain the actual financial figures, which would have been detailed in the earlier results filing. The full advertisement is also available on the company's website.
This is purely a procedural regulatory filing confirming newspaper publication of already-filed quarterly results; it carries no new financial information and is unlikely to have any direct impact on the stock price.